GlassScriptPhysician profile
Jeremiah E Bast
NPI 1790270106
$1,688.63
in general payments reported to CMS, 2019-2025
17 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $200 · 2022: $499 · 2023: $565 · 2024: $260 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $890 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $889.75 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $520.97 | 2021-2024 | Xtandi, Myrbetriq |
| Urovant Sciences INC | $193.46 | 2021-2022 | |
| Antares Pharma, INC. | $169.91 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Sumitomo Pharma America, INC. | $114.26 | 2023-2024 | Gemtesa, Orgovyx |
| Axonics, INC. | $92.32 | 2023-2024 | Axonics |
| Halozyme INC | $81.03 | 2023 | |
| 180 Medical, INC. | $80.94 | 2022-2024 | Gentlecath, Gentlecath Glide |
| Janssen Biotech, INC. | $78.15 | 2021-2023 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $63.89 | 2025 | |
| Abbvie INC. | $59.49 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $59.01 | 2022-2023 | Lynparza, Keytruda |
| Boston Scientific Corporation | $41.94 | 2024 | Ams 700 |
| Pfizer INC. | $37.89 | 2023-2025 | |
| Coloplast Corp | $35.59 | 2024-2025 | |
| Urogen Pharma, INC. | $29.99 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $14.93 | 2021 | |
| Tolmar, INC. | $14.86 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremiah Bast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.